My Healthy Today
Meeting Your Personal Health Information Needs
Home E-Health Services Sample News Subscribe Feedback Contact Us
UserName Password Forgot Password?
 
 
What's New
New Uses Click Here to Subscribe
E-Health Services
My Health Newsletter™
My Health Reminders™
My Health Reminders for Loved Ones™
My Baby Expectations™
My Health Links™
Health Information
Click Here
Daily Health News
Latest News
FYI
Health Highlights
FDA Approvals
Recommend these Services
Newsletter Topics
Allergy
Alternative Medicine
Alzheimer's Disease
Anxiety
Arthritis
Asthma
Blood Pressure
Breast Cancer
Cancer
Chronic Illness
Dental Care
Depression
Diabetes
Exercise / Fitness
Female Urological Disorders
Fertility
Gastrointestinal Health
Healthy Diet
Heart Disease
Men's Health
Menopause
Neurology
Orthopedics
Pain Management
Parenting
Pediatrics
Pregnancy
Rehabilitation
Senior Caregiving
Seniors' Health
Skin Health
Sleep Disorders
Sports Medicine
Stroke Rehabilitation
Vision
Weight Management
Weight Management and Kids
Women's Health
Women's Heart Health
 
 
  FDA Approvals
Return to
Daily Health Main Page.

  Nucleic Acid Test Screens for HIV
 
  In donated blood and tissue

 

WEDNESDAY, Dec. 31 (HealthDay News) -- The U.S. Food and Drug Administration has approved the nation's first nucleic acid test to detect the presence of HIV in donated blood and tissue.

Nucleic acid is a chemical compound that makes up the genetic material in cells. The cobas TaqScreen MPX Test screens for nucleic acid from HIV-2 and HIV-1 Group O, strains of HIV that are commonly found in Africa, the agency said in a news release. These infections also have been detected in the United States.

In addition, the test detects the most common form of the virus that causes AIDS, HIV-1 Group M, as well as two forms of hepatitis -- hepatitis C and hepatitis B.

The test is designed to be used on blood specimens obtained when the donor's heart is still beating. It's not meant to test plasma intended for further manufacturing.

The test is produced by California-based Roche Molecular Systems Inc.

More information

To learn more about HIV testing, visit the U.S. Department of Health and Human Services.

 
 
   More   FDA Approvals
 
   •  Degarelix Approved for Advanced Prostate Cancer
  Suppresses testosterone production
 
   •  Gleevec Approved for Use After Cancer Surgery
  Drug first sanctioned in 2001
 
   •  Zolpimist Approved for Insomnia
  Oral spray contains Ambien's active ingredient
 
   •  Mozobil Boosts Stem Cells Before Bone Marrow Transplants
  Could help people with certain forms of blood cancer
 
   
Health Content Provided By:
  The health content is provided for informational and educational purposes. It is intended for the general population and may not reflect specific conditions or risk of an individual or segment of the population. Therefore, it is not intended to be a substitute for professional medical advice, consultation, treatment or diagnosis. Always seek the advice of your physician or other qualified health provider with questions. Never disregard professional medical advice or delay in seeking it because of information obtained through these services.
 
 
   
 
©2002 Private Health News. All Rights Reserved.
Home | E-Health Services | Sample News | Subscribe | Feedback | Contact Us
Privacy Policy | Terms & Conditions